Back to Search Start Over

Role of ALK5/SMAD2/3 signaling in the regulation of NOX expression in cerebral ischemia/reperfusion injury.

Authors :
Lou, Zheng
Wang, Ai-Ping
Duan, Xiao-Ming
Hu, Guo-Huang
Zuo, Mei-Ling
Yang, Zhong-Bao
Source :
Experimental & Therapeutic Medicine. Sep2018, Vol. 16 Issue 3, p1671-1678. 8p.
Publication Year :
2018

Abstract

Nicotinamide adenine dinucleotide phosphate oxidase (NOX)-derived reactive oxygen species (ROS) serve an important role in cerebral ischemia/reperfusion (I/R) injury. However, the mechanism by which ROS generation is regulated has not yet been fully elucidated. The present study aimed to explore the role of transforming growth factor-ß signaling in ROS generation. Sprague Dawley rats were subjected to I/R injury and PC-12 cells were transfected with small interfering RNA against activin receptor-like kinase (ALK)5 or hypoxia/reoxygenation (H/R). The results indicated that I/R or H/R significantly increased ALK5 expression, SMAD2/3 phosphorylation and NOX2/4 expression and activity, concomitant with ROS generation and apoptosis. In addition, ALK5 knockdown significantly reversed changes induced by H/R treatment in PC-12 cells. These results suggest that ALK5/SMAD2/3 signaling serves a key role in oxidative stress. To the best of our knowledge, this is the first study to demonstrate that ALK5/SMAD2/3 activation is associated with the regulation of NOX2/4 expression and exacerbates I/R injury. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17920981
Volume :
16
Issue :
3
Database :
Academic Search Index
Journal :
Experimental & Therapeutic Medicine
Publication Type :
Academic Journal
Accession number :
131240155
Full Text :
https://doi.org/10.3892/etm.2018.6377